kitio.aiArteraAI vs Proscia
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. ArteraAI starts at See pricing page and Proscia starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
- Concentriq pathology platform
- AI case review tools
- Biomarker research
- Clinical trial support
- Companion diagnostics
- Partner AI applications
| Feature | ArteraAI | Proscia |
|---|---|---|
| Best for | AI pathology tests that predict cancer outcomes and therapy benefit | Digital pathology platform with AI for labs and drug developers |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Artera | Proscia |
| Based in | United States | United States |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
ArteraAI starts at See pricing page and Proscia starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Oct 29, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
ArteraAI
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
Proscia
- Serves both clinical labs and pharma
- Best in KLAS 2026 for digital pathology
- Open to partner AI algorithms
- No public pricing
- Only for pathology and life sciences
- Pending acquisition may change the roadmap
Which one should you choose?
Choose ArteraAI if you want:
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Watch out: ordered by clinicians only.
Choose Proscia if you want:
- Serves both clinical labs and pharma
- Best in KLAS 2026 for digital pathology
- Open to partner AI algorithms
Watch out: no public pricing.
ArteraAI vs Proscia FAQ
What is the difference between ArteraAI and Proscia?
ArteraAI: AI pathology tests that predict cancer outcomes and therapy benefit. Proscia: Digital pathology platform with AI for labs and drug developers. Both are legal, finance & hr tools.
Is ArteraAI or Proscia cheaper?
ArteraAI starts at See pricing page and Proscia starts at See pricing page. Check both pricing pages for current plans.
Do ArteraAI and Proscia have free plans?
ArteraAI: No. Proscia: No.
Who makes ArteraAI?
ArteraAI is made by Artera, based in United States.
Who makes Proscia?
Proscia is made by Proscia, based in United States.
Which should I choose, ArteraAI or Proscia?
Choose ArteraAI if you value fda de novo authorization and listed in nccn prostate guidelines. Choose Proscia if you value serves both clinical labs and pharma and best in klas 2026 for digital pathology.